Medicinal plants and natural products for treating overactive bladder. Date Tuesday, March 26, 2024 - 10:00 PM Description Chinese Medicine; 03/27/2024(AN 176264764); ISSN: 17498546Complementary Index
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority Date Tuesday, February 06, 2024 - 10:00 PM Description PR Newswire US; 02/07/2024(AN 202402070630PR.NEWS.USPR.VA30990)Business Source Corporate Plus
MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market Date Tuesday, September 26, 2023 - 10:00 PM Description PR Newswire US; 09/27/2023(AN 202309270715PR.NEWS.USPR.VA21454)Business Source Corporate Plus
MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status Date Monday, July 31, 2023 - 10:00 PM Description PR Newswire US; 08/01/2023(AN 202308010700PR.NEWS.USPR.VA70917)Business Source Corporate Plus
MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients Date Wednesday, August 30, 2023 - 10:00 PM Description PR Newswire US; 08/31/2023(AN 202308310730PR.NEWS.USPR.VA97535)Business Source Corporate Plus
MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth Date Sunday, August 13, 2023 - 10:00 PM Description PR Newswire US; 08/14/2023(AN 202308140713PR.NEWS.USPR.VA82849)Business Source Corporate Plus
MediPharm Labs Reports Third Quarter Results Date Monday, November 13, 2023 - 10:00 PM Description PR Newswire US; 11/14/2023(AN 202311140715PR.NEWS.USPR.VA67736)Business Source Corporate Plus
MediPharm Labs Reports Third Quarter Results. Date Monday, November 27, 2023 - 10:00 PM Description Cannabis & Marijuana News; 11/28/2023(AN 173753472)Complementary Index
MediPharm Labs Settles an Outstanding Claim for $9M Date Sunday, October 01, 2023 - 10:00 PM Description PR Newswire US; 10/02/2023(AN 202310020700PR.NEWS.USPR.VA26425)Business Source Corporate Plus
MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash Date Tuesday, October 24, 2023 - 10:00 PM Description PR Newswire US; 10/25/2023(AN 202310250700PR.NEWS.USPR.VA47705)Business Source Corporate Plus